A multiplex immunoassay is a type of assay capable of simultaneously measuring multiple analytes in a single cycle of the assay. These are widely utilized in experiments of functional genomics seeking detection of state of all biomolecules of given class in a biological sample. The developments in multiplex immunoassays is attributed to increasing requirement for enhanced procedures of disease analytics along with minimized errors and diminished costs. The possibility of multiplex immunoassays of providing quantitative information via parallel examinations is a promising development. The global multiplex detection immunoassay market is projected to witness 7.5% CAGR during 2016 to 2024, according to a study by Persistence Market Research (PMR).
Growing Geriatric Population and Healthcare Infrastructure to Boost the Growth of Multiplex Immunoassay Market
Growing geriatric population inclined to chronic infections and immune system sickness is expected to propel the growth of global multiplex detection immunoassay market. The prominence of multiplex assay in purpose of care or clinical diagnostic is attributed to its capacity to produce reportable outcomes through a single specimen. Owing to soaring government expenditure in medical improvement and clinical diagnostics as well as robust growth of healthcare infrastructure, the global multiplex detection immunoassay market is expected to register a significant development in the near future. In addition, rapid growth of medical technologies and cost-effective treatment among regions of Latin America and Asia Pacific are some other prominent factors driving the overall market.
Impeding Factors for Growth of Multiplex Immunoassay Market
However factors such as stringent administrative endorsements and lack of reimbursement policies are expected to confine the development of multiplex immunoassays. Improvement of multiplexed immunoassays involve thorough assay configuration approval and systematic execution for minimizing inaccuracy and test imprecision. Challenges associated with multiplex immunoassays setup incorporate determination & immobilization of alignment, capture ligands, impedance in proteins and antibodies. Owing to financial drawbacks of some countries in adoption of new technology, the growth of global multiplex detection immunoassay market is expected to be restricted.
Opportunity Created for Researchers Owing to Emergence of Multiplex Immunoassays
For more than five decades, immunoassays have helped researchers in the identification and monitoring of protein expression by using an antibody that specifically targets the protein of interest and a report or label that is measured. Immunoassay’s application was once limited to basic research but they have extended into clinical-research and diagnostic spaces. Owing to emergence of multiplex immunoassays, an opportunity has been created for researchers to access excess information on a series of protein in a single reaction of an experiment.
Multiplex immunoassays not only help in gathering more information in short time but also conserve expensive, precious and/or significantly small volume samples. Researchers are adopting to rising number of available multiplex immunoassay tools for investigation of cellular regulatory events occurring in cancer. Pharmaceutical industries are adopting to multiplex immunoassays for increasing their testing power.
Bio-Rad’s Bio-Plex Pro Mouse Chemokine Panel
Many companies have come up with various technologies in the global multiplex detection immunoassay market. Bio-Rad Laboratories, Inc. recently made an announcement of introducing its “Bio-Plex Pro Mouse Chemokine Panel”, the latest in its array of magnetic bead-based multiplex immunoassays. This panel is capable of detecting more panel as compared to any other available assay, permitting researchers for harnessing more data with each run. The Bio-Rad’s Bio-Plex Pro Mouse Chemokine Panel provides highest sample detectability with actionable and clear results.
Benefits of Bio-Plex Pro Mouse Chemokine Panel Include
- High Sensitivity & High Signal-to-Noise Ratio– provides improved sample detectability with the help of optimized reagents to offer a broad dynamic range
- Wide Coverage of Panel– detects a large number of biologically relevant targets in single well.
- Ready to Use (Premixed) Reagents– streamlines workflow with a simplified protocol and premixed reagents
For more information visit @ http://www.persistencemarketresearch.com/market-research/multiplex-detection-immunoassay-market.asp